Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis
Molecules · 2023
DOI: 10.3390/molecules28237797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Tingting Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, An…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Berberine, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Laboratory of Neutronics and Radiation Safety, Chinese Academy of Sciences, the Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
Low-temperature plasma (LTP) is an emerging biomedical technique that has been proposed as a potential approach for cancer therapy. Meanwhile, berberine (BER), an active ingredient extracted from various medical herbs, such as Coptischinesis, has been proven antitumor effects in a broad spectrum of cancer cells. In this study, we seek to develop a novel dual cancer therapeutic method by integrating pre-administration of BER and LTP exposure and evaluating its comprehensive antitumor effect on the human non-small-cell lung cancer (NSCLC) cell lines (A549 and H1299) in vitro. Cell viability, cell cycle, cell apoptosis, and intracellular and extracellular ROS were investigated. The results showed that cotreatment of BER and LTP significantly decreased the cell viability, arrested the cell cycle in the S phase, promoted cell apoptosis, and increased intracellular and extracellular ROS. Additionally, RNA Sequencing (RNA-Seq) technology was used to explore potential mechanisms. The differentially expressed genes among different treatment groups of NSCLC cells were analyzed and were mainly enriched in the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Moreover, cotreatment of BER and LTP notably depressed the total protein expression level of PI3K and AKT with immunoblotting. In conclusion, BER and LTP have a synergistic inhibitory effect on NSCLC cells via the PI3K-AKT signaling pathway, which could provide a promising strategy for supplementary therapy in the anti-NSCLC battle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases, Anhui University of Chinese Medicine, Hefei 230012, China.
- Anhui Province Key Laboratory of Medical Physics, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
- Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei 230012, China.
- Key Laboratory of Neutronics and Radiation Safety, Chinese Academy of Sciences, Hefei 230031, China.
- International Academy of Neutron Science, Qingdao 266199, China.
Förderung
- National Natural Science Foundation of China
- Key Laboratory of Neutronics and Radiation Safety, Chinese Academy of Sciences
- the Natural Science Foundation of Anhui Province
- the Anhui Province University Outstanding Young Talents Support Program
- the Anhui University of Chinese Medicine 2021 First Batch of High-level Talents Support Program
- Anhui University Graduate Scientific Research Program
- the New Era Education Quality Project of Anhui Provincial Department of Education
- the National Innovation and Entrepreneurship Training Program for College Students
Zitieren
APA
Lu, T., Wang, Y., Liu, F., Zhang, L., Huang, S., Zhou, Y., Wu, H., Mao, Y., Jin, C., & Song, W. (2023). Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis. Molecules. https://doi.org/10.3390/molecules28237797
Vancouver
Lu T, Wang Y, Liu F, Zhang L, Huang S, Zhou Y, et al. Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis. Molecules. 2023. doi:10.3390/molecules28237797
BibTeX
@article{Lu2023,
author = {Lu, Tingting and Wang, Yu and Liu, Fang and Zhang, Lu and Huang, Simin and Zhou, Yuanyuan and Wu, Hui and Mao, Yanmei and Jin, Chufeng and Song, Wencheng},
title = {Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28237797}
}
EUVIMED